Tumor	NN	B-NP	B-protein	B-Protein	###	1	Tumor	Tumor	NN	NN	_	4	compound	_	_
necrosis	NN	I-NP	I-protein	I-Protein	###	2	necrosis	necrosis	NN	NN	_	4	compound	_	_
factor	NN	I-NP	I-protein	I-Protein	###	3	factor	factor	NN	NN	_	4	compound	_	_
alpha	NN	I-NP	I-protein	I-Protein	###	4	alpha	alpha	NN	NN	_	5	nsubj	_	_
decreases	VBZ	B-VP	O	Other	###	5	decreases	decreases	VBZ	VBZ	_	0	root	_	_
,	,	O	O	Other	###	6	,	,	,	,	_	5	punct	_	_
and	CC	O	O	Other	###	7	and	and	CC	CC	_	5	cc	_	_
interleukin-10	NN	B-NP	B-protein	B-Protein	###	8	interleukin-10	interleukin-10	NN	NN	_	9	compound	_	_
increases	NNS	I-NP	O	Other	###	9	increases	increases	NNS	NNS	_	5	conj	_	_
,	,	O	O	Other	###	10	,	,	,	,	_	5	punct	_	_
the	DT	B-NP	O	Other	###	11	the	the	DT	DT	_	12	det	_	_
sensitivity	NN	I-NP	O	Other	###	12	sensitivity	sensitivity	NN	NN	_	5	conj	_	_
of	IN	B-PP	O	Other	###	13	of	of	IN	IN	_	15	case	_	_
human	JJ	B-NP	B-cell_type	Other	###	14	human	human	JJ	JJ	_	15	amod	_	_
monocytes	NNS	I-NP	I-cell_type	Other	###	15	monocytes	monocytes	NNS	NNS	_	12	nmod	_	_
to	TO	B-PP	O	Other	###	16	to	to	TO	TO	_	17	case	_	_
dexamethasone	NN	B-NP	O	Other	###	17	dexamethasone	dexamethasone	NN	NN	_	12	nmod	_	_
:	:	O	O	Other	###	18	:	:	:	:	_	5	punct	_	_
potential	JJ	B-NP	O	Other	###	19	potential	potential	JJ	JJ	_	20	amod	_	_
regulation	NN	I-NP	O	Other	###	20	regulation	regulation	NN	NN	_	5	dep	_	_
of	IN	B-PP	O	Other	###	21	of	of	IN	IN	_	24	case	_	_
the	DT	B-NP	O	Other	###	22	the	the	DT	DT	_	24	det	_	_
glucocorticoid	NN	I-NP	B-protein	B-Protein	###	23	glucocorticoid	glucocorticoid	NN	NN	_	24	compound	_	_
receptor	NN	I-NP	I-protein	I-Protein	###	24	receptor	receptor	NN	NN	_	20	nmod	_	_
.	.	O	O	Other	###	25	.	.	.	.	_	20	punct	_	_

Resistance	NN	B-NP	O	Other	###	1	Resistance	Resistance	NN	NN	_	7	nsubjpass	_	_
to	TO	B-PP	O	Other	###	2	to	to	TO	TO	_	4	case	_	_
glucocorticoid	NN	B-NP	O	Other	###	3	glucocorticoid	glucocorticoid	NN	NN	_	4	compound	_	_
therapy	NN	I-NP	O	Other	###	4	therapy	therapy	NN	NN	_	1	nmod	_	_
has	VBZ	B-VP	O	Other	###	5	has	has	VBZ	VBZ	_	7	aux	_	_
been	VBN	I-VP	O	Other	###	6	been	been	VBN	VBN	_	7	auxpass	_	_
observed	VBN	I-VP	O	Other	###	7	observed	observed	VBN	VBN	_	0	root	_	_
in	IN	B-PP	O	Other	###	8	in	in	IN	IN	_	9	case	_	_
patients	NNS	B-NP	O	Other	###	9	patients	patients	NNS	NNS	_	7	nmod	_	_
with	IN	B-PP	O	Other	###	10	with	with	IN	IN	_	14	case	_	_
autoimmune	JJ	B-NP	O	Other	###	11	autoimmune	autoimmune	JJ	JJ	_	14	amod	_	_
/	/	O	O	Other	###	12	/	/	/	/	_	14	punct	_	_
inflammatory	JJ	B-NP	O	Other	###	13	inflammatory	inflammatory	JJ	JJ	_	11	dep	_	_
diseases	NNS	I-NP	O	Other	###	14	diseases	diseases	NNS	NNS	_	9	nmod	_	_
and	CC	O	O	Other	###	15	and	and	CC	CC	_	7	cc	_	_
may	MD	B-VP	O	Other	###	16	may	may	MD	MD	_	18	aux	_	_
be	VB	I-VP	O	Other	###	17	be	be	VB	VB	_	18	cop	_	_
related	JJ	B-ADJP	O	Other	###	18	related	related	JJ	JJ	_	7	conj	_	_
to	TO	B-PP	O	Other	###	19	to	to	TO	TO	_	22	case	_	_
the	DT	B-NP	O	Other	###	20	the	the	DT	DT	_	22	det	_	_
inflammatory	JJ	I-NP	O	Other	###	21	inflammatory	inflammatory	JJ	JJ	_	22	amod	_	_
process	NN	I-NP	O	Other	###	22	process	process	NN	NN	_	18	nmod	_	_
itself	PRP	B-NP	O	Other	###	23	itself	itself	PRP	PRP	_	22	nmod:npmod	_	_
.	.	O	O	Other	###	24	.	.	.	.	_	7	punct	_	_

The	DT	B-NP	O	Other	###	1	The	The	DT	DT	_	2	det	_	_
aim	NN	I-NP	O	Other	###	2	aim	aim	NN	NN	_	6	nsubj	_	_
of	IN	B-PP	O	Other	###	3	of	of	IN	IN	_	5	case	_	_
this	DT	B-NP	O	Other	###	4	this	this	DT	DT	_	5	det	_	_
study	NN	I-NP	O	Other	###	5	study	study	NN	NN	_	2	nmod	_	_
was	VBD	B-VP	O	Other	###	6	was	was	VBD	VBD	_	0	root	_	_
to	TO	B-VP	O	Other	###	7	to	to	TO	TO	_	8	mark	_	_
examine	VB	I-VP	O	Other	###	8	examine	examine	VB	VB	_	6	xcomp	_	_
the	DT	B-NP	O	Other	###	9	the	the	DT	DT	_	10	det	_	_
ability	NN	I-NP	O	Other	###	10	ability	ability	NN	NN	_	8	dobj	_	_
of	IN	B-PP	O	Other	###	11	of	of	IN	IN	_	15	case	_	_
tumor	NN	B-NP	B-protein	B-Protein	###	12	tumor	tumor	NN	NN	_	15	compound	_	_
necrosis	NN	I-NP	I-protein	I-Protein	###	13	necrosis	necrosis	NN	NN	_	15	compound	_	_
factor	NN	I-NP	I-protein	I-Protein	###	14	factor	factor	NN	NN	_	15	compound	_	_
alpha	NN	I-NP	I-protein	I-Protein	###	15	alpha	alpha	NN	NN	_	10	nmod	_	_
(	(	O	O	Other	###	16	(	(	(	(	_	17	punct	_	_
TNFalpha	NN	B-NP	B-protein	B-Protein	###	17	TNFalpha	TNFalpha	NN	NN	_	15	dep	_	_
,	,	O	O	Other	###	18	,	,	,	,	_	17	punct	_	_
a	DT	B-NP	O	Other	###	19	a	a	DT	DT	_	21	det	_	_
proinflammatory	JJ	I-NP	B-protein	Other	###	20	proinflammatory	proinflammatory	JJ	JJ	_	21	amod	_	_
cytokine	NN	I-NP	I-protein	Other	###	21	cytokine	cytokine	NN	NN	_	17	appos	_	_
)	)	O	O	Other	###	22	)	)	)	)	_	17	punct	_	_
and	CC	O	O	Other	###	23	and	and	CC	CC	_	15	cc	_	_
interleukin	NN	I-NP	I-protein	B-Protein	###	24	interleukin	interleukin	NN	NN	_	25	compound	_	_
(IL)-10	NN	I-NP	I-protein	I-Protein	###	25	(IL)-10	(IL)-10	NN	NN	_	15	conj	_	_
(	(	O	O	Other	###	26	(	(	(	(	_	29	punct	_	_
an	DT	B-NP	O	Other	###	27	an	an	DT	DT	_	29	det	_	_
anti-inflammatory	JJ	I-NP	B-protein	Other	###	28	anti-inflammatory	anti-inflammatory	JJ	JJ	_	29	amod	_	_
cytokine	NN	I-NP	I-protein	Other	###	29	cytokine	cytokine	NN	NN	_	25	appos	_	_
)	)	O	O	Other	###	30	)	)	)	)	_	29	punct	_	_
to	TO	B-VP	O	Other	###	31	to	to	TO	TO	_	33	mark	_	_
differentially	RB	I-VP	O	Other	###	32	differentially	differentially	RB	RB	_	33	advmod	_	_
regulate	VB	I-VP	O	Other	###	33	regulate	regulate	VB	VB	_	10	acl	_	_
the	DT	B-NP	O	Other	###	34	the	the	DT	DT	_	35	det	_	_
sensitivity	NN	I-NP	O	Other	###	35	sensitivity	sensitivity	NN	NN	_	33	dobj	_	_
of	IN	B-PP	O	Other	###	36	of	of	IN	IN	_	38	case	_	_
human	JJ	B-NP	B-cell_type	Other	###	37	human	human	JJ	JJ	_	38	amod	_	_
monocytes	NNS	I-NP	I-cell_type	Other	###	38	monocytes	monocytes	NNS	NNS	_	35	nmod	_	_
/	/	O	O	Other	###	39	/	/	/	/	_	38	punct	_	_
macrophages	NNS	I-NP	I-cell_type	Other	###	40	macrophages	macrophages	NNS	NNS	_	38	dep	_	_
to	TO	B-PP	O	Other	###	41	to	to	TO	TO	_	42	case	_	_
glucocorticoids	NNS	B-NP	O	Other	###	42	glucocorticoids	glucocorticoids	NNS	NNS	_	35	nmod	_	_
.	.	O	O	Other	###	43	.	.	.	.	_	6	punct	_	_

To	TO	B-VP	O	Other	###	1	To	To	TO	TO	_	2	mark	_	_
accomplish	VB	I-VP	O	Other	###	2	accomplish	accomplish	VB	VB	_	7	advcl	_	_
this	DT	B-NP	O	Other	###	3	this	this	DT	DT	_	2	dobj	_	_
,	,	O	O	Other	###	4	,	,	,	,	_	7	punct	_	_
we	PRP	B-NP	O	Other	###	5	we	we	PRP	PRP	_	7	nsubj	_	_
first	RB	B-ADVP	O	Other	###	6	first	first	RB	RB	_	7	advmod	_	_
analyzed	VBD	B-VP	O	Other	###	7	analyzed	analyzed	VBD	VBD	_	0	root	_	_
the	DT	B-NP	O	Other	###	8	the	the	DT	DT	_	9	det	_	_
pattern	NN	I-NP	O	Other	###	9	pattern	pattern	NN	NN	_	7	dobj	_	_
of	IN	B-PP	O	Other	###	10	of	of	IN	IN	_	14	case	_	_
TNFalpha	NN	B-NP	B-protein	B-Protein	###	11	TNFalpha	TNFalpha	NN	NN	_	14	compound	_	_
and	CC	I-NP	O	Other	###	12	and	and	CC	CC	_	11	cc	_	_
IL-10	NN	I-NP	B-protein	B-Protein	###	13	IL-10	IL-10	NN	NN	_	11	conj	_	_
inhibition	NN	I-NP	O	Other	###	14	inhibition	inhibition	NN	NN	_	9	nmod	_	_
by	IN	B-PP	O	Other	###	15	by	by	IN	IN	_	16	case	_	_
dexamethasone	NN	B-NP	O	Other	###	16	dexamethasone	dexamethasone	NN	NN	_	9	nmod	_	_
in	IN	B-PP	O	Other	###	17	in	in	IN	IN	_	23	case	_	_
LPS	JJ	B-NP	B-cell_line	Other	###	18	LPS	LPS	JJ	JJ	_	23	compound	_	_
-	-	O	O	Other	###	19	-	-	-	-	_	23	punct	_	_
stimulated	JJ	B-NP	B-cell_line	Other	###	20	stimulated	stimulated	JJ	JJ	_	23	amod	_	_
whole-blood	JJ	I-NP	I-cell_line	Other	###	21	whole-blood	whole-blood	JJ	JJ	_	23	amod	_	_
cell	NN	I-NP	I-cell_line	Other	###	22	cell	cell	NN	NN	_	23	compound	_	_
cultures	NNS	I-NP	I-cell_line	Other	###	23	cultures	cultures	NNS	NNS	_	16	nmod	_	_
.	.	O	O	Other	###	24	.	.	.	.	_	7	punct	_	_

Second	RB	B-ADVP	O	Other	###	1	Second	Second	RB	RB	_	4	advmod	_	_
,	,	O	O	Other	###	2	,	,	,	,	_	4	punct	_	_
we	PRP	B-NP	O	Other	###	3	we	we	PRP	PRP	_	4	nsubj	_	_
studied	VBD	B-VP	O	Other	###	4	studied	studied	VBD	VBD	_	0	root	_	_
the	DT	B-NP	O	Other	###	5	the	the	DT	DT	_	6	det	_	_
modulation	NN	I-NP	O	Other	###	6	modulation	modulation	NN	NN	_	4	dobj	_	_
of	IN	B-PP	O	Other	###	7	of	of	IN	IN	_	9	case	_	_
the	DT	B-NP	O	Other	###	8	the	the	DT	DT	_	9	det	_	_
sensitivity	NN	I-NP	O	Other	###	9	sensitivity	sensitivity	NN	NN	_	6	nmod	_	_
of	IN	B-PP	O	Other	###	10	of	of	IN	IN	_	12	case	_	_
these	DT	B-NP	O	Other	###	11	these	these	DT	DT	_	12	det	_	_
cells	NNS	I-NP	O	Other	###	12	cells	cells	NNS	NNS	_	9	nmod	_	_
to	TO	B-PP	O	Other	###	13	to	to	TO	TO	_	14	case	_	_
dexamethasone	NN	B-NP	O	Other	###	14	dexamethasone	dexamethasone	NN	NN	_	9	nmod	_	_
by	IN	B-PP	O	Other	###	15	by	by	IN	IN	_	16	case	_	_
preincubation	NN	B-NP	O	Other	###	16	preincubation	preincubation	NN	NN	_	4	nmod	_	_
with	IN	B-PP	O	Other	###	17	with	with	IN	IN	_	18	case	_	_
TNFalpha	NN	B-NP	B-protein	B-Protein	###	18	TNFalpha	TNFalpha	NN	NN	_	16	nmod	_	_
or	CC	I-NP	O	Other	###	19	or	or	CC	CC	_	18	cc	_	_
IL-10	NN	I-NP	B-protein	B-Protein	###	20	IL-10	IL-10	NN	NN	_	18	conj	_	_
and	CC	I-NP	O	Other	###	21	and	and	CC	CC	_	16	cc	_	_
measurement	NN	I-NP	O	Other	###	22	measurement	measurement	NN	NN	_	16	conj	_	_
of	IN	B-PP	O	Other	###	23	of	of	IN	IN	_	28	case	_	_
LPS	JJ	B-NP	O	Other	###	24	LPS	LPS	JJ	JJ	_	28	compound	_	_
-	-	O	O	Other	###	25	-	-	-	-	_	26	punct	_	_
stimulated	JJ	B-NP	O	Other	###	26	stimulated	stimulated	JJ	JJ	_	24	dep	_	_
IL-6	NN	I-NP	B-protein	B-Protein	###	27	IL-6	IL-6	NN	NN	_	28	compound	_	_
secretion	NN	I-NP	O	Other	###	28	secretion	secretion	NN	NN	_	22	nmod	_	_
.	.	O	O	Other	###	29	.	.	.	.	_	4	punct	_	_

In	IN	B-PP	O	Other	###	1	In	In	IN	IN	_	2	case	_	_
addition	NN	B-NP	O	Other	###	2	addition	addition	NN	NN	_	5	nmod	_	_
,	,	O	O	Other	###	3	,	,	,	,	_	5	punct	_	_
we	PRP	B-NP	O	Other	###	4	we	we	PRP	PRP	_	5	nsubj	_	_
evaluated	VBD	B-VP	O	Other	###	5	evaluated	evaluated	VBD	VBD	_	0	root	_	_
the	DT	B-NP	O	Other	###	6	the	the	DT	DT	_	7	det	_	_
effect	NN	I-NP	O	Other	###	7	effect	effect	NN	NN	_	5	dobj	_	_
of	IN	B-PP	O	Other	###	8	of	of	IN	IN	_	9	case	_	_
dexamethasone	NN	B-NP	O	Other	###	9	dexamethasone	dexamethasone	NN	NN	_	7	nmod	_	_
on	IN	B-PP	O	Other	###	10	on	on	IN	IN	_	17	case	_	_
phorbolmyristate-acetate	JJ	B-NP	O	Other	###	11	phorbolmyristate-acetate	phorbolmyristate-acetate	JJ	JJ	_	17	amod	_	_
-	-	O	O	Other	###	12	-	-	-	-	_	11	punct	_	_
stimulated	JJ	B-NP	O	Other	###	13	stimulated	stimulated	JJ	JJ	_	11	dep	_	_
IL-1	NN	I-NP	O	B-Protein	###	14	IL-1	IL-1	NN	NN	_	17	compound	_	_
receptor	NN	I-NP	O	I-Protein	###	15	receptor	receptor	NN	NN	_	17	compound	_	_
antagonist	NN	I-NP	O	I-Protein	###	16	antagonist	antagonist	NN	NN	_	17	compound	_	_
secretion	NN	I-NP	O	Other	###	17	secretion	secretion	NN	NN	_	7	nmod	_	_
by	IN	B-PP	O	Other	###	18	by	by	IN	IN	_	24	case	_	_
the	DT	B-NP	O	Other	###	19	the	the	DT	DT	_	24	det	_	_
human	JJ	I-NP	B-cell_line	Other	###	20	human	human	JJ	JJ	_	24	amod	_	_
monocytic	JJ	I-NP	I-cell_line	Other	###	21	monocytic	monocytic	JJ	JJ	_	24	amod	_	_
cell	NN	I-NP	I-cell_line	Other	###	22	cell	cell	NN	NN	_	24	compound	_	_
line	NN	I-NP	I-cell_line	Other	###	23	line	line	NN	NN	_	24	compound	_	_
U937	NN	I-NP	I-cell_line	Other	###	24	U937	U937	NN	NN	_	17	nmod	_	_
.	.	O	O	Other	###	25	.	.	.	.	_	5	punct	_	_

Finally	RB	B-ADVP	O	Other	###	1	Finally	Finally	RB	RB	_	4	advmod	_	_
,	,	O	O	Other	###	2	,	,	,	,	_	4	punct	_	_
we	PRP	B-NP	O	Other	###	3	we	we	PRP	PRP	_	4	nsubj	_	_
investigated	VBD	B-VP	O	Other	###	4	investigated	investigated	VBD	VBD	_	0	root	_	_
whether	IN	B-SBAR	O	Other	###	5	whether	whether	IN	IN	_	20	mark	_	_
the	DT	B-NP	O	Other	###	6	the	the	DT	DT	_	7	det	_	_
modulation	NN	I-NP	O	Other	###	7	modulation	modulation	NN	NN	_	20	nsubj	_	_
of	IN	B-PP	O	Other	###	8	of	of	IN	IN	_	9	case	_	_
corticosensitivity	NN	B-NP	O	Other	###	9	corticosensitivity	corticosensitivity	NN	NN	_	7	nmod	_	_
in	IN	B-PP	O	Other	###	10	in	in	IN	IN	_	11	case	_	_
TNFalpha	NN	B-NP	B-protein	B-Protein	###	11	TNFalpha	TNFalpha	NN	NN	_	7	nmod	_	_
-	-	O	O	Other	###	12	-	-	-	-	_	11	punct	_	_
and	CC	O	I-cell_line	Other	###	13	and	and	CC	CC	_	11	cc	_	_
IL-10	NN	B-NP	B-protein	B-Protein	###	14	IL-10	IL-10	NN	NN	_	11	conj	_	_
-	-	O	O	Other	###	15	-	-	-	-	_	18	punct	_	_
pretreated	NN	B-NP	O	Other	###	16	pretreated	pretreated	NN	NN	_	18	amod	_	_
U937	NN	I-NP	I-cell_line	Other	###	17	U937	U937	NN	NN	_	18	compound	_	_
cells	NNS	I-NP	I-cell_line	Other	###	18	cells	cells	NNS	NNS	_	11	dep	_	_
was	VBD	B-VP	O	Other	###	19	was	was	VBD	VBD	_	20	cop	_	_
related	VBN	I-VP	O	Other	###	20	related	related	VBN	VBN	_	4	ccomp	_	_
to	TO	B-PP	O	Other	###	21	to	to	TO	TO	_	23	case	_	_
a	DT	B-NP	O	Other	###	22	a	a	DT	DT	_	23	det	_	_
change	NN	I-NP	O	Other	###	23	change	change	NN	NN	_	20	nmod	_	_
of	IN	B-PP	O	Other	###	24	of	of	IN	IN	_	27	case	_	_
the	DT	B-NP	O	Other	###	25	the	the	DT	DT	_	27	det	_	_
glucocorticoid	NN	I-NP	B-protein	B-Protein	###	26	glucocorticoid	glucocorticoid	NN	NN	_	27	compound	_	_
receptor	NN	I-NP	I-protein	I-Protein	###	27	receptor	receptor	NN	NN	_	23	nmod	_	_
concentration	NN	I-NP	O	Other	###	28	concentration	concentration	NN	NN	_	27	dep	_	_
and	CC	O	O	Other	###	29	and	and	CC	CC	_	28	cc	_	_
affinity	NN	B-NP	O	Other	###	30	affinity	affinity	NN	NN	_	28	conj	_	_
.	.	O	O	Other	###	31	.	.	.	.	_	4	punct	_	_

Dexamethasone	NN	B-NP	O	Other	###	1	Dexamethasone	Dexamethasone	NN	NN	_	2	nsubj	_	_
had	VBD	B-VP	O	Other	###	2	had	had	VBD	VBD	_	0	root	_	_
different	JJ	B-NP	O	Other	###	3	different	different	JJ	JJ	_	4	amod	_	_
effects	NNS	I-NP	O	Other	###	4	effects	effects	NNS	NNS	_	2	dobj	_	_
on	IN	B-PP	O	Other	###	5	on	on	IN	IN	_	12	case	_	_
LPS	JJ	B-NP	O	Other	###	6	LPS	LPS	JJ	JJ	_	9	compound	_	_
-	-	O	O	Other	###	7	-	-	-	-	_	6	punct	_	_
induced	JJ	B-NP	O	Other	###	8	induced	induced	JJ	JJ	_	9	amod	_	_
TNFalpha	NN	I-NP	B-protein	B-Protein	###	9	TNFalpha	TNFalpha	NN	NN	_	2	nmod	_	_
and	CC	I-NP	O	Other	###	10	and	and	CC	CC	_	9	cc	_	_
IL-10	NN	I-NP	B-protein	B-Protein	###	11	IL-10	IL-10	NN	NN	_	9	conj	_	_
secretion	NN	I-NP	O	Other	###	12	secretion	secretion	NN	NN	_	9	dep	_	_
;	:	O	O	Other	###	13	;	;	:	:	_	2	punct	_	_
whereas	IN	B-SBAR	O	Other	###	14	whereas	whereas	IN	IN	_	16	mark	_	_
it	PRP	B-NP	O	Other	###	15	it	it	PRP	PRP	_	16	nsubj	_	_
suppressed	VBD	B-VP	O	Other	###	16	suppressed	suppressed	VBD	VBD	_	2	advcl	_	_
TNFalpha	NN	B-NP	B-protein	B-Protein	###	17	TNFalpha	TNFalpha	NN	NN	_	16	dobj	_	_
in	IN	B-PP	O	Other	###	18	in	in	IN	IN	_	23	case	_	_
a	DT	B-NP	O	Other	###	19	a	a	DT	DT	_	23	det	_	_
dose	JJ	I-NP	O	Other	###	20	dose	dose	JJ	JJ	_	23	amod	_	_
-	-	O	O	Other	###	21	-	-	-	-	_	23	punct	_	_
dependent	JJ	I-NP	O	Other	###	22	dependent	dependent	JJ	JJ	_	20	dep	_	_
fashion	NN	I-NP	O	Other	###	23	fashion	fashion	NN	NN	_	16	nmod	_	_
,	,	O	O	Other	###	24	,	,	,	,	_	31	punct	_	_
its	PRP$	B-NP	O	Other	###	25	its	its	PRP$	PRP$	_	26	nmod:poss	_	_
effect	NN	I-NP	O	Other	###	26	effect	effect	NN	NN	_	31	nsubj	_	_
on	IN	B-PP	O	Other	###	27	on	on	IN	IN	_	29	case	_	_
IL-10	NN	B-NP	B-protein	B-Protein	###	28	IL-10	IL-10	NN	NN	_	29	compound	_	_
secretion	NN	I-NP	O	Other	###	29	secretion	secretion	NN	NN	_	26	nmod	_	_
was	VBD	B-VP	O	Other	###	30	was	was	VBD	VBD	_	31	cop	_	_
biphasic	JJ	B-ADJP	O	Other	###	31	biphasic	biphasic	JJ	JJ	_	2	parataxis	_	_
,	,	O	O	Other	###	32	,	,	,	,	_	31	punct	_	_
producing	VBG	B-VP	O	Other	###	33	producing	producing	VBG	VBG	_	31	xcomp	_	_
stimulation	NN	B-NP	O	Other	###	34	stimulation	stimulation	NN	NN	_	33	dobj	_	_
at	IN	B-PP	O	Other	###	35	at	at	IN	IN	_	36	case	_	_
lower	JJR	B-ADJP	O	Other	###	36	lower	lower	JJR	JJR	_	34	acl	_	_
,	,	O	O	Other	###	37	,	,	,	,	_	34	punct	_	_
and	CC	O	O	Other	###	38	and	and	CC	CC	_	34	cc	_	_
inhibition	NN	B-NP	O	Other	###	39	inhibition	inhibition	NN	NN	_	34	conj	_	_
at	IN	B-PP	O	Other	###	40	at	at	IN	IN	_	42	case	_	_
higher	JJR	B-NP	O	Other	###	41	higher	higher	JJR	JJR	_	42	amod	_	_
doses	NNS	I-NP	O	Other	###	42	doses	doses	NNS	NNS	_	34	acl	_	_
.	.	O	O	Other	###	43	.	.	.	.	_	2	punct	_	_

The	DT	B-NP	O	Other	###	1	The	The	DT	DT	_	2	det	_	_
concentration	NN	I-NP	O	Other	###	2	concentration	concentration	NN	NN	_	6	nsubj	_	_
of	IN	B-PP	O	Other	###	3	of	of	IN	IN	_	4	case	_	_
LPS	NN	B-NP	O	Other	###	4	LPS	LPS	NN	NN	_	2	nmod	_	_
employed	VBN	B-VP	O	Other	###	5	employed	employed	VBN	VBN	_	4	acl	_	_
influenced	VBD	B-VP	O	Other	###	6	influenced	influenced	VBD	VBD	_	0	root	_	_
the	DT	B-NP	O	Other	###	7	the	the	DT	DT	_	8	det	_	_
effect	NN	I-NP	O	Other	###	8	effect	effect	NN	NN	_	6	dobj	_	_
of	IN	B-PP	O	Other	###	9	of	of	IN	IN	_	10	case	_	_
dexamethasone	NN	B-NP	O	Other	###	10	dexamethasone	dexamethasone	NN	NN	_	8	nmod	_	_
on	IN	B-PP	O	Other	###	11	on	on	IN	IN	_	13	case	_	_
IL-10	NN	B-NP	B-protein	B-Protein	###	12	IL-10	IL-10	NN	NN	_	13	compound	_	_
secretion	NN	I-NP	O	Other	###	13	secretion	secretion	NN	NN	_	8	nmod	_	_
(	(	O	O	Other	###	14	(	(	(	(	_	16	punct	_	_
P	NN	B-NP	O	Other	###	15	P	P	NN	NN	_	16	compound	_	_
<	SYM	O	O	Other	###	16	<	<	SYM	SYM	_	17	dep	_	_
0.001	CD	B-NP	O	Other	###	17	0.001	0.001	CD	CD	_	13	dep	_	_
)	)	O	O	Other	###	18	)	)	)	)	_	16	punct	_	_
.	.	O	O	Other	###	19	.	.	.	.	_	6	punct	_	_

Pretreatment	NN	B-NP	O	Other	###	1	Pretreatment	Pretreatment	NN	NN	_	4	nsubj	_	_
with	IN	B-PP	O	Other	###	2	with	with	IN	IN	_	3	case	_	_
TNFalpha	NN	B-NP	B-protein	B-Protein	###	3	TNFalpha	TNFalpha	NN	NN	_	1	nmod	_	_
diminished	VBD	B-VP	O	Other	###	4	diminished	diminished	VBD	VBD	_	0	root	_	_
,	,	O	O	Other	###	5	,	,	,	,	_	4	punct	_	_
and	CC	O	O	Other	###	6	and	and	CC	CC	_	4	cc	_	_
with	IN	B-PP	O	Other	###	7	with	with	IN	IN	_	8	case	_	_
IL-10	NN	B-NP	B-protein	B-Protein	###	8	IL-10	IL-10	NN	NN	_	9	nsubj	_	_
improved	VBD	B-VP	O	Other	###	9	improved	improved	VBD	VBD	_	4	conj	_	_
,	,	O	O	Other	###	10	,	,	,	,	_	4	punct	_	_
the	DT	B-NP	O	Other	###	11	the	the	DT	DT	_	12	det	_	_
ability	NN	I-NP	O	Other	###	12	ability	ability	NN	NN	_	4	dep	_	_
of	IN	B-PP	O	Other	###	13	of	of	IN	IN	_	14	case	_	_
dexamethasone	NN	B-NP	O	Other	###	14	dexamethasone	dexamethasone	NN	NN	_	12	nmod	_	_
to	TO	B-VP	O	Other	###	15	to	to	TO	TO	_	16	mark	_	_
suppress	VB	I-VP	O	Other	###	16	suppress	suppress	VB	VB	_	12	dep	_	_
IL-6	NN	B-NP	B-protein	B-Protein	###	17	IL-6	IL-6	NN	NN	_	18	compound	_	_
secretion	NN	I-NP	O	Other	###	18	secretion	secretion	NN	NN	_	16	dobj	_	_
in	IN	B-PP	O	Other	###	19	in	in	IN	IN	_	22	case	_	_
whole-blood	JJ	B-NP	B-cell_line	Other	###	20	whole-blood	whole-blood	JJ	JJ	_	22	amod	_	_
cell	NN	I-NP	I-cell_line	Other	###	21	cell	cell	NN	NN	_	22	compound	_	_
cultures	NNS	I-NP	I-cell_line	Other	###	22	cultures	cultures	NNS	NNS	_	16	nmod	_	_
(	(	O	O	Other	###	23	(	(	(	(	_	26	punct	_	_
P	NN	B-NP	O	Other	###	24	P	P	NN	NN	_	26	nsubj	_	_
<	JJR	B-NP	O	Other	###	25	<	<	JJR	JJR	_	26	dep	_	_
0.01	CD	I-NP	O	Other	###	26	0.01	0.01	CD	CD	_	16	parataxis	_	_
for	IN	B-PP	O	Other	###	27	for	for	IN	IN	_	28	case	_	_
both	DT	B-NP	O	Other	###	28	both	both	DT	DT	_	26	nmod	_	_
)	)	O	O	Other	###	29	)	)	)	)	_	26	punct	_	_
and	CC	O	O	Other	###	30	and	and	CC	CC	_	16	cc	_	_
to	TO	B-VP	O	Other	###	31	to	to	TO	TO	_	32	mark	_	_
enhance	VB	I-VP	O	Other	###	32	enhance	enhance	VB	VB	_	16	conj	_	_
IL-1	NN	B-NP	B-protein	B-Protein	###	33	IL-1	IL-1	NN	NN	_	36	compound	_	_
receptor	NN	I-NP	O	I-Protein	###	34	receptor	receptor	NN	NN	_	36	compound	_	_
antagonist	NN	I-NP	O	I-Protein	###	35	antagonist	antagonist	NN	NN	_	36	compound	_	_
secretion	NN	I-NP	O	Other	###	36	secretion	secretion	NN	NN	_	32	dobj	_	_
by	IN	B-PP	O	Other	###	37	by	by	IN	IN	_	39	case	_	_
U937	NN	B-NP	B-cell_line	Other	###	38	U937	U937	NN	NN	_	39	compound	_	_
cells	NNS	I-NP	I-cell_line	Other	###	39	cells	cells	NNS	NNS	_	36	nmod	_	_
(	(	O	O	Other	###	40	(	(	(	(	_	43	punct	_	_
P	NN	B-NP	O	Other	###	41	P	P	NN	NN	_	43	nsubj	_	_
<	JJR	B-NP	O	Other	###	42	<	<	JJR	JJR	_	43	dep	_	_
0.05	CD	I-NP	O	Other	###	43	0.05	0.05	CD	CD	_	32	parataxis	_	_
for	IN	B-PP	O	Other	###	44	for	for	IN	IN	_	45	case	_	_
both	DT	B-NP	O	Other	###	45	both	both	DT	DT	_	43	nmod	_	_
)	)	O	O	Other	###	46	)	)	)	)	_	43	punct	_	_
.	.	O	O	Other	###	47	.	.	.	.	_	4	punct	_	_

TNFalpha	NN	B-NP	B-protein	B-Protein	###	1	TNFalpha	TNFalpha	NN	NN	_	2	nsubj	_	_
decreased	VBD	B-VP	O	Other	###	2	decreased	decreased	VBD	VBD	_	0	root	_	_
(	(	O	O	Other	###	3	(	(	(	(	_	6	punct	_	_
P	NN	B-NP	O	Other	###	4	P	P	NN	NN	_	6	nsubj	_	_
<	SYM	O	O	Other	###	5	<	<	SYM	SYM	_	6	dep	_	_
0.001	CD	B-NP	O	Other	###	6	0.001	0.001	CD	CD	_	2	parataxis	_	_
)	)	O	O	Other	###	7	)	)	)	)	_	6	punct	_	_
,	,	O	O	Other	###	8	,	,	,	,	_	2	punct	_	_
while	IN	B-SBAR	O	Other	###	9	while	while	IN	IN	_	11	mark	_	_
IL-10	NN	B-NP	B-protein	B-Protein	###	10	IL-10	IL-10	NN	NN	_	11	nsubj	_	_
increased	VBD	B-VP	O	Other	###	11	increased	increased	VBD	VBD	_	2	advcl	_	_
(	(	O	O	Other	###	12	(	(	(	(	_	15	punct	_	_
P	NN	B-NP	O	Other	###	13	P	P	NN	NN	_	15	nsubj	_	_
<	SYM	O	O	Other	###	14	<	<	SYM	SYM	_	15	dep	_	_
0.001	CD	B-NP	O	Other	###	15	0.001	0.001	CD	CD	_	11	parataxis	_	_
)	)	O	O	Other	###	16	)	)	)	)	_	15	punct	_	_
,	,	O	O	Other	###	17	,	,	,	,	_	11	punct	_	_
the	DT	B-NP	O	Other	###	18	the	the	DT	DT	_	19	det	_	_
concentration	NN	I-NP	O	Other	###	19	concentration	concentration	NN	NN	_	11	dobj	_	_
of	IN	B-PP	O	Other	###	20	of	of	IN	IN	_	23	case	_	_
dexamethasone	NN	B-NP	B-DNA	Other	###	21	dexamethasone	dexamethasone	NN	NN	_	23	compound	_	_
binding	NN	I-NP	I-DNA	Other	###	22	binding	binding	NN	NN	_	23	compound	_	_
sites	NNS	I-NP	I-DNA	Other	###	23	sites	sites	NNS	NNS	_	19	nmod	_	_
in	IN	B-PP	O	Other	###	24	in	in	IN	IN	_	26	case	_	_
these	DT	B-NP	O	Other	###	25	these	these	DT	DT	_	26	det	_	_
cells	NNS	I-NP	O	Other	###	26	cells	cells	NNS	NNS	_	19	nmod	_	_
,	,	O	O	Other	###	27	,	,	,	,	_	11	punct	_	_
with	IN	B-PP	O	Other	###	28	with	with	IN	IN	_	31	case	_	_
no	DT	B-NP	O	Other	###	29	no	no	DT	DT	_	31	neg	_	_
discernible	JJ	I-NP	O	Other	###	30	discernible	discernible	JJ	JJ	_	31	amod	_	_
effect	NN	I-NP	O	Other	###	31	effect	effect	NN	NN	_	11	nmod	_	_
on	IN	B-PP	O	Other	###	32	on	on	IN	IN	_	35	case	_	_
their	PRP$	B-NP	O	Other	###	33	their	their	PRP$	PRP$	_	35	nmod:poss	_	_
binding	NN	I-NP	O	Other	###	34	binding	binding	NN	NN	_	35	compound	_	_
affinity	NN	I-NP	O	Other	###	35	affinity	affinity	NN	NN	_	31	nmod	_	_
.	.	O	O	Other	###	36	.	.	.	.	_	2	punct	_	_

We	PRP	B-NP	O	Other	###	1	We	We	PRP	PRP	_	2	nsubj	_	_
conclude	VBP	B-VP	O	Other	###	2	conclude	conclude	VBP	VBP	_	0	root	_	_
that	IN	B-SBAR	O	Other	###	3	that	that	IN	IN	_	6	mark	_	_
glucocorticoids	NNS	B-NP	O	Other	###	4	glucocorticoids	glucocorticoids	NNS	NNS	_	6	nsubj	_	_
differentially	RB	B-ADVP	O	Other	###	5	differentially	differentially	RB	RB	_	6	advmod	_	_
modulate	VBP	B-VP	O	Other	###	6	modulate	modulate	VBP	VBP	_	2	ccomp	_	_
TNFalpha	NN	B-NP	B-protein	B-Protein	###	7	TNFalpha	TNFalpha	NN	NN	_	10	compound	_	_
and	CC	I-NP	O	Other	###	8	and	and	CC	CC	_	7	cc	_	_
IL-10	NN	I-NP	B-protein	B-Protein	###	9	IL-10	IL-10	NN	NN	_	7	conj	_	_
secretion	NN	I-NP	O	Other	###	10	secretion	secretion	NN	NN	_	6	dobj	_	_
by	IN	B-PP	O	Other	###	11	by	by	IN	IN	_	13	case	_	_
human	JJ	B-NP	B-cell_type	Other	###	12	human	human	JJ	JJ	_	13	amod	_	_
monocytes	NNS	I-NP	I-cell_type	Other	###	13	monocytes	monocytes	NNS	NNS	_	6	nmod	_	_
in	IN	B-PP	O	Other	###	14	in	in	IN	IN	_	20	case	_	_
a	DT	B-NP	O	Other	###	15	a	a	DT	DT	_	20	det	_	_
LPS	NN	I-NP	O	Other	###	16	LPS	LPS	NN	NN	_	17	compound	_	_
dose	JJ	I-NP	O	Other	###	17	dose	dose	JJ	JJ	_	20	amod	_	_
-	-	O	O	Other	###	18	-	-	-	-	_	20	punct	_	_
dependent	JJ	I-NP	O	Other	###	19	dependent	dependent	JJ	JJ	_	20	amod	_	_
fashion	NN	I-NP	O	Other	###	20	fashion	fashion	NN	NN	_	6	nmod	_	_
and	CC	O	O	Other	###	21	and	and	CC	CC	_	6	cc	_	_
that	IN	B-SBAR	O	Other	###	22	that	that	IN	IN	_	31	mark	_	_
the	DT	B-NP	O	Other	###	23	the	the	DT	DT	_	24	det	_	_
sensitivity	NN	I-NP	O	Other	###	24	sensitivity	sensitivity	NN	NN	_	31	nsubjpass	_	_
of	IN	B-PP	O	Other	###	25	of	of	IN	IN	_	27	case	_	_
these	DT	B-NP	O	Other	###	26	these	these	DT	DT	_	27	det	_	_
cells	NNS	I-NP	O	Other	###	27	cells	cells	NNS	NNS	_	24	nmod	_	_
to	TO	B-PP	O	Other	###	28	to	to	TO	TO	_	29	case	_	_
glucocorticoids	NNS	B-NP	O	Other	###	29	glucocorticoids	glucocorticoids	NNS	NNS	_	24	nmod	_	_
is	VBZ	B-VP	O	Other	###	30	is	is	VBZ	VBZ	_	31	auxpass	_	_
altered	VBN	I-VP	O	Other	###	31	altered	altered	VBN	VBN	_	6	conj	_	_
by	IN	B-PP	O	Other	###	32	by	by	IN	IN	_	33	case	_	_
TNFalpha	NN	B-NP	B-protein	B-Protein	###	33	TNFalpha	TNFalpha	NN	NN	_	31	nmod	_	_
or	CC	I-NP	O	Other	###	34	or	or	CC	CC	_	33	cc	_	_
IL-10	NN	I-NP	B-protein	B-Protein	###	35	IL-10	IL-10	NN	NN	_	33	conj	_	_
pretreatment	NN	I-NP	O	Other	###	36	pretreatment	pretreatment	NN	NN	_	33	dep	_	_
;	:	O	O	Other	###	37	;	;	:	:	_	31	punct	_	_
TNFalpha	NN	B-NP	B-protein	B-Protein	###	38	TNFalpha	TNFalpha	NN	NN	_	39	nsubj	_	_
blocks	VBZ	B-VP	O	Other	###	39	blocks	blocks	VBZ	VBZ	_	31	parataxis	_	_
their	PRP$	B-NP	O	Other	###	40	their	their	PRP$	PRP$	_	41	nmod:poss	_	_
effects	NNS	I-NP	O	Other	###	41	effects	effects	NNS	NNS	_	39	dobj	_	_
,	,	O	O	Other	###	42	,	,	,	,	_	39	punct	_	_
whereas	IN	O	O	Other	###	43	whereas	whereas	IN	IN	_	39	dep	_	_
IL-10	NN	B-NP	B-protein	B-Protein	###	44	IL-10	IL-10	NN	NN	_	45	nsubj	_	_
acts	VBZ	B-VP	O	Other	###	45	acts	acts	VBZ	VBZ	_	39	parataxis	_	_
synergistically	RB	B-ADVP	O	Other	###	46	synergistically	synergistically	RB	RB	_	45	advmod	_	_
with	IN	B-PP	O	Other	###	47	with	with	IN	IN	_	48	case	_	_
glucocorticoids	NNS	B-NP	O	Other	###	48	glucocorticoids	glucocorticoids	NNS	NNS	_	45	nmod	_	_
.	.	O	O	Other	###	49	.	.	.	.	_	2	punct	_	_

This	DT	B-NP	O	Other	###	1	This	This	DT	DT	_	3	nsubjpass	_	_
is	VBZ	B-VP	O	Other	###	2	is	is	VBZ	VBZ	_	3	auxpass	_	_
accompanied	VBN	I-VP	O	Other	###	3	accompanied	accompanied	VBN	VBN	_	0	root	_	_
by	IN	B-PP	O	Other	###	4	by	by	IN	IN	_	8	case	_	_
opposite	JJ	B-NP	O	Other	###	5	opposite	opposite	JJ	JJ	_	8	amod	_	_
glucocorticoid	NN	I-NP	B-protein	B-Protein	###	6	glucocorticoid	glucocorticoid	NN	NN	_	8	compound	_	_
receptor	NN	I-NP	I-protein	I-Protein	###	7	receptor	receptor	NN	NN	_	8	compound	_	_
changes	NNS	I-NP	O	Other	###	8	changes	changes	NNS	NNS	_	3	nmod	_	_
,	,	O	O	Other	###	9	,	,	,	,	_	8	punct	_	_
respectively	RB	B-VP	O	Other	###	10	respectively	respectively	RB	RB	_	11	advmod	_	_
opposing	VBG	I-VP	O	Other	###	11	opposing	opposing	VBG	VBG	_	8	dep	_	_
and	CC	I-VP	O	Other	###	12	and	and	CC	CC	_	11	cc	_	_
favoring	VBG	I-VP	O	Other	###	13	favoring	favoring	VBG	VBG	_	11	conj	_	_
glucocorticoid	NN	B-NP	O	Other	###	14	glucocorticoid	glucocorticoid	NN	NN	_	15	compound	_	_
actions	NNS	I-NP	O	Other	###	15	actions	actions	NNS	NNS	_	11	dobj	_	_
.	.	O	O	Other	###	16	.	.	.	.	_	3	punct	_	_

This	DT	B-NP	O	Other	###	1	This	This	DT	DT	_	2	det	_	_
study	NN	I-NP	O	Other	###	2	study	study	NN	NN	_	3	nsubj	_	_
suggests	VBZ	B-VP	O	Other	###	3	suggests	suggests	VBZ	VBZ	_	0	root	_	_
that	IN	B-SBAR	O	Other	###	4	that	that	IN	IN	_	15	mark	_	_
the	DT	B-NP	O	Other	###	5	the	the	DT	DT	_	6	det	_	_
pattern	NN	I-NP	O	Other	###	6	pattern	pattern	NN	NN	_	15	nsubj	_	_
of	IN	B-PP	O	Other	###	7	of	of	IN	IN	_	13	case	_	_
pro	JJ	B-NP	O	Other	###	8	pro	pro	JJ	JJ	_	13	amod	_	_
-	-	O	O	Other	###	9	-	-	-	-	_	8	punct	_	_
/	/	O	O	Other	###	10	/	/	/	/	_	11	punct	_	_
antiinflammatory	JJ	B-NP	O	Other	###	11	antiinflammatory	antiinflammatory	JJ	JJ	_	13	amod	_	_
cytokine	NN	I-NP	B-protein	Other	###	12	cytokine	cytokine	NN	NN	_	13	compound	_	_
secretion	NN	I-NP	O	Other	###	13	secretion	secretion	NN	NN	_	6	nmod	_	_
may	MD	B-VP	O	Other	###	14	may	may	MD	MD	_	15	aux	_	_
alter	VB	I-VP	O	Other	###	15	alter	alter	VB	VB	_	3	ccomp	_	_
the	DT	B-NP	O	Other	###	16	the	the	DT	DT	_	17	det	_	_
response	NN	I-NP	O	Other	###	17	response	response	NN	NN	_	15	dobj	_	_
of	IN	B-PP	O	Other	###	18	of	of	IN	IN	_	19	case	_	_
patients	NNS	B-NP	O	Other	###	19	patients	patients	NNS	NNS	_	17	nmod	_	_
to	TO	B-PP	O	Other	###	20	to	to	TO	TO	_	22	case	_	_
glucocorticoid	NN	B-NP	O	Other	###	21	glucocorticoid	glucocorticoid	NN	NN	_	22	compound	_	_
therapy	NN	I-NP	O	Other	###	22	therapy	therapy	NN	NN	_	17	nmod	_	_
.	.	O	O	Other	###	23	.	.	.	.	_	3	punct	_	_

